Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01

Recall Number: D-0720-2021

Firm: Eli Lilly & Company

Classification: Class II

Status: Terminated

Report Date: 20210818

Initiation Date: 20210629

Termination Date: 20230729

cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01